Prevention of Coronary Hyperreactivity in Preatherogenic Menopausal Rhesus Monkeys by Transdermal Progesterone

R. Kent Hermsmeyer, Rajesh G. Mishra, Dusan Pavcnik, Barry Uchida, Michael Axthelm, Frank Z. Stanczyk, Kenneth A. Burry, D. Roger Illingworth, Juan Carlos Kaski, Frank J. Nordt

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objective-To test if transdermal progesterone (P) confers coronary vascular protection in surgically menopausal preatherosclerotic rhesus monkeys. Methods and Results-Ovariectomized rhesus monkeys fed an atherogenic diet (AD) for 19 months were treated with an investigational transdermal P cream (n=7) or identical placebo cream (n=5) for 4 weeks. Aorta and carotids showed fatty streaks and Oil Red O staining demonstrated lipid deposition. Serum P levels in P-treated rhesus monkeys (0.6 ng/mL) were significantly greater than placebo (0.2 ng/mL). Significant elevation of cholesterol, LDL cholesterol, and HDL cholesterol, was noted in all animals. Lp(a) was significantly attenuated in the AD-fed P-treated monkeys. Coronary angiographic experiments stimulating vasoconstriction by intracoronary injections of serotonin plus U46619 showed exaggerated prolonged actions amplified by AD, but significant protection against severe prolonged vasoconstriction in P-treated monkeys. Immunocytochemistry confirmed co-expression of P and thromboxane prostanoid (TP) receptors in coronaries and aorta. Western blotting demonstrated TP receptor attenuation in vascular muscle after P treatment. Conclusions-Coronary hyperreactivity, a putative component of coronary artery disease mediated via increased vascular muscle thromboxane prostanoid receptors, can be prevented by subphysiological levels of P, not only in nonatherosclerotic (previously shown) but also in preatherosclerotic primates.

Original languageEnglish (US)
Pages (from-to)955-961
Number of pages7
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume24
Issue number5
DOIs
StatePublished - May 2004

Fingerprint

Thromboxane Receptors
Atherogenic Diet
Macaca mulatta
Prostaglandins
Progesterone
Blood Vessels
Vasoconstriction
Haplorhini
Aorta
Placebos
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Muscles
LDL Cholesterol
HDL Cholesterol
Primates
Coronary Artery Disease
Serotonin
Western Blotting
Immunohistochemistry
Cholesterol

Keywords

  • Cardiac catheterization
  • Coronary occlusion
  • Menopause
  • Progesterone replacement

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Prevention of Coronary Hyperreactivity in Preatherogenic Menopausal Rhesus Monkeys by Transdermal Progesterone. / Hermsmeyer, R. Kent; Mishra, Rajesh G.; Pavcnik, Dusan; Uchida, Barry; Axthelm, Michael; Stanczyk, Frank Z.; Burry, Kenneth A.; Illingworth, D. Roger; Kaski, Juan Carlos; Nordt, Frank J.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 24, No. 5, 05.2004, p. 955-961.

Research output: Contribution to journalArticle

Hermsmeyer, R. Kent ; Mishra, Rajesh G. ; Pavcnik, Dusan ; Uchida, Barry ; Axthelm, Michael ; Stanczyk, Frank Z. ; Burry, Kenneth A. ; Illingworth, D. Roger ; Kaski, Juan Carlos ; Nordt, Frank J. / Prevention of Coronary Hyperreactivity in Preatherogenic Menopausal Rhesus Monkeys by Transdermal Progesterone. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2004 ; Vol. 24, No. 5. pp. 955-961.
@article{91fe8c07e4bd47dd82bd9a35307eeaf9,
title = "Prevention of Coronary Hyperreactivity in Preatherogenic Menopausal Rhesus Monkeys by Transdermal Progesterone",
abstract = "Objective-To test if transdermal progesterone (P) confers coronary vascular protection in surgically menopausal preatherosclerotic rhesus monkeys. Methods and Results-Ovariectomized rhesus monkeys fed an atherogenic diet (AD) for 19 months were treated with an investigational transdermal P cream (n=7) or identical placebo cream (n=5) for 4 weeks. Aorta and carotids showed fatty streaks and Oil Red O staining demonstrated lipid deposition. Serum P levels in P-treated rhesus monkeys (0.6 ng/mL) were significantly greater than placebo (0.2 ng/mL). Significant elevation of cholesterol, LDL cholesterol, and HDL cholesterol, was noted in all animals. Lp(a) was significantly attenuated in the AD-fed P-treated monkeys. Coronary angiographic experiments stimulating vasoconstriction by intracoronary injections of serotonin plus U46619 showed exaggerated prolonged actions amplified by AD, but significant protection against severe prolonged vasoconstriction in P-treated monkeys. Immunocytochemistry confirmed co-expression of P and thromboxane prostanoid (TP) receptors in coronaries and aorta. Western blotting demonstrated TP receptor attenuation in vascular muscle after P treatment. Conclusions-Coronary hyperreactivity, a putative component of coronary artery disease mediated via increased vascular muscle thromboxane prostanoid receptors, can be prevented by subphysiological levels of P, not only in nonatherosclerotic (previously shown) but also in preatherosclerotic primates.",
keywords = "Cardiac catheterization, Coronary occlusion, Menopause, Progesterone replacement",
author = "Hermsmeyer, {R. Kent} and Mishra, {Rajesh G.} and Dusan Pavcnik and Barry Uchida and Michael Axthelm and Stanczyk, {Frank Z.} and Burry, {Kenneth A.} and Illingworth, {D. Roger} and Kaski, {Juan Carlos} and Nordt, {Frank J.}",
year = "2004",
month = "5",
doi = "10.1161/01.ATV.0000126372.14332.70",
language = "English (US)",
volume = "24",
pages = "955--961",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Prevention of Coronary Hyperreactivity in Preatherogenic Menopausal Rhesus Monkeys by Transdermal Progesterone

AU - Hermsmeyer, R. Kent

AU - Mishra, Rajesh G.

AU - Pavcnik, Dusan

AU - Uchida, Barry

AU - Axthelm, Michael

AU - Stanczyk, Frank Z.

AU - Burry, Kenneth A.

AU - Illingworth, D. Roger

AU - Kaski, Juan Carlos

AU - Nordt, Frank J.

PY - 2004/5

Y1 - 2004/5

N2 - Objective-To test if transdermal progesterone (P) confers coronary vascular protection in surgically menopausal preatherosclerotic rhesus monkeys. Methods and Results-Ovariectomized rhesus monkeys fed an atherogenic diet (AD) for 19 months were treated with an investigational transdermal P cream (n=7) or identical placebo cream (n=5) for 4 weeks. Aorta and carotids showed fatty streaks and Oil Red O staining demonstrated lipid deposition. Serum P levels in P-treated rhesus monkeys (0.6 ng/mL) were significantly greater than placebo (0.2 ng/mL). Significant elevation of cholesterol, LDL cholesterol, and HDL cholesterol, was noted in all animals. Lp(a) was significantly attenuated in the AD-fed P-treated monkeys. Coronary angiographic experiments stimulating vasoconstriction by intracoronary injections of serotonin plus U46619 showed exaggerated prolonged actions amplified by AD, but significant protection against severe prolonged vasoconstriction in P-treated monkeys. Immunocytochemistry confirmed co-expression of P and thromboxane prostanoid (TP) receptors in coronaries and aorta. Western blotting demonstrated TP receptor attenuation in vascular muscle after P treatment. Conclusions-Coronary hyperreactivity, a putative component of coronary artery disease mediated via increased vascular muscle thromboxane prostanoid receptors, can be prevented by subphysiological levels of P, not only in nonatherosclerotic (previously shown) but also in preatherosclerotic primates.

AB - Objective-To test if transdermal progesterone (P) confers coronary vascular protection in surgically menopausal preatherosclerotic rhesus monkeys. Methods and Results-Ovariectomized rhesus monkeys fed an atherogenic diet (AD) for 19 months were treated with an investigational transdermal P cream (n=7) or identical placebo cream (n=5) for 4 weeks. Aorta and carotids showed fatty streaks and Oil Red O staining demonstrated lipid deposition. Serum P levels in P-treated rhesus monkeys (0.6 ng/mL) were significantly greater than placebo (0.2 ng/mL). Significant elevation of cholesterol, LDL cholesterol, and HDL cholesterol, was noted in all animals. Lp(a) was significantly attenuated in the AD-fed P-treated monkeys. Coronary angiographic experiments stimulating vasoconstriction by intracoronary injections of serotonin plus U46619 showed exaggerated prolonged actions amplified by AD, but significant protection against severe prolonged vasoconstriction in P-treated monkeys. Immunocytochemistry confirmed co-expression of P and thromboxane prostanoid (TP) receptors in coronaries and aorta. Western blotting demonstrated TP receptor attenuation in vascular muscle after P treatment. Conclusions-Coronary hyperreactivity, a putative component of coronary artery disease mediated via increased vascular muscle thromboxane prostanoid receptors, can be prevented by subphysiological levels of P, not only in nonatherosclerotic (previously shown) but also in preatherosclerotic primates.

KW - Cardiac catheterization

KW - Coronary occlusion

KW - Menopause

KW - Progesterone replacement

UR - http://www.scopus.com/inward/record.url?scp=2442421179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442421179&partnerID=8YFLogxK

U2 - 10.1161/01.ATV.0000126372.14332.70

DO - 10.1161/01.ATV.0000126372.14332.70

M3 - Article

VL - 24

SP - 955

EP - 961

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 5

ER -